Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Alprostadil

Summary

Persistence. It cannot be excluded that alprostadil is persistent, due to the lack of data.

Bioaccumulation. Alprostadil has low potential for bioaccumulation.

Toxicity. It cannot be excluded that alprostadil is toxic, due to the lack of data.

Risk. Risk of environmental impact of alprostadil cannot be excluded, due to the lack of environmental toxicity data.

 

This summary information comes from Fass.

Detailed information

Fass environmental information for Bondil

Fass environmental information for Bondil (alprostadil) from Viatris (downloaded 2023-05-24). The environmental information for alprostadil is produced by the company Ferring for Vitaros. Vitaros is no longer approved.

Hazard

Persistence: No data.

Bioaccumulation: An experimentally derived Log P of 3,20 (unknown method) ... indicates that alprostadil has low potential for bioaccumulation.

Toxicity: No data.

Risk

Risk of environmental impact of alprostadil cannot be excluded, due to the lack of environmental toxicity data.

Fass environmental information for Caverject Dual

Fass environmental information for Caverject Dual (alprostadil) from Pfizer (downloaded 2023-05-24).

Hazard

Persistence: No data.

Bioaccumulation: No data.

Toxicity: No data.

Risk

Risk of environmental impact of alprostadil cannot be excluded, due to the lack of environmental toxicity data.

Author: Health and Medical Care Administration, Region Stockholm